Dashboard Market News Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
AFT Pharmaceuticals Ltd banner
A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 4.32 NZD -1.59% Market Closed
Market Cap: NZ$453m
Write Note Create Alert Ask AI

Wall St Price Targets

AFT Price Targets Summary
AFT Pharmaceuticals Ltd

Wall Street analysts forecast AFT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFT is 4.74 NZD with a low forecast of 4.29 NZD and a high forecast of 5.3 NZD.

AFT Lowest Forecast
Wall Street Target
NZ$4.29
-1% Downside
AFT Average Forecast
Wall Street Target
NZ$4.74
10% Upside
AFT Highest Forecast
Wall Street Target
NZ$5.3
23% Upside
Lowest Forecast
Price Target
4.29 NZD
1% Downside
Average Forecast
Price Target
4.74 NZD
10% Upside
Highest Forecast
Price Target
5.3 NZD
23% Upside
AFT Pharmaceuticals Ltd Competitors:
Price Targets

Revenue
Forecast

15% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
15% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 4 years is 15%.

What are analyst estimates?

Gross Profit
Forecast

15% / Year
Past Growth
-13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
15% / Year
Past Growth
-13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 1 year is -13%.

What are analyst estimates?

Operating Income
Forecast

27% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
27% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 27%. The projected CAGR for the next 4 years is 20%.

What are analyst estimates?

Pre-Tax Income
Forecast

39% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat
39% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
11%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 39%. The projected CAGR for the next 3 years is 26%.

What are analyst estimates?

Net Income
Forecast

41% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat
41% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 41%. The projected CAGR for the next 4 years is 23%.

What are analyst estimates?

Continue AFT Research

Summary
AFT intrinsic value, competitors valuation, and company profile.
DCF Valuation
AFT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AFT stock valuation using valuation multiples.
Wall St Estimates
AFT price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AFT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other AFT Pharmaceuticals Ltd listings:
ASX • AUD
AFP
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AFT's stock price target?
Price Target
4.74 NZD

According to Wall Street analysts, the average 1-year price target for AFT is 4.74 NZD with a low forecast of 4.29 NZD and a high forecast of 5.3 NZD.

What is the Revenue forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 4 years is 15%.

What is the Gross Profit forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
-13%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 1 year is -13%.

What is the Operating Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Operating Income has been 27%. The projected CAGR for the next 4 years is 20%.

What is the Pre-Tax Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
26%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 39%. The projected CAGR for the next 3 years is 26%.

What is the Net Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
23%

Over the last 13 years, the compound annual growth rate for Net Income has been 41%. The projected CAGR for the next 4 years is 23%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.